Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Arthritis Rheumatol. 2023 Mar 7;75(5):748–759. doi: 10.1002/art.42418

Fig. 2 – Reactivity of PR3-ANCA positive serum samples with iHm5 and iPR3.

Fig. 2 –

Representative examples of serum samples from patients with PR3-ANCA associated vasculitis showing higher (A and B) or equal (C and D) binding to iHm5 compared to iPR3 in the anchor ELISA.